Arax Advisory Partners’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Arax Advisory Partners's RPRX Position: Q2 2026 in Review
Arax Advisory Partners increased its Royalty Pharma (RPRX) stake by 819% in Q2 2026, buying an estimated $496K and bringing the position to 10,703 shares worth $600K. The position accounts for ﹤0.01% of the portfolio, ranked #1523.
Arax Advisory Partners first reported a position in RPRX in Q2 2024 and has held it in 9 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Arax Advisory Partners held 10,703 shares of Royalty Pharma worth $600K as of Q2 2026.
- Arax Advisory Partners bought 9,538 Royalty Pharma shares in Q2 2026, an estimated $496K.
- Royalty Pharma made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1523 holding.
- Arax Advisory Partners first reported a position in Royalty Pharma in Q2 2024 and has held it in 9 quarters since.
- 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.